[{"address1": "2450 Holcombe Blvd", "address2": "MS: BCM251", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "713 400 6400", "website": "https://markertherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Juan F. Vera M.D.", "age": 44, "title": "Co-Founder, CEO, President, Treasurer, Secretary & Director", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 400000, "exercisedValue": 0, "unexercisedValue": 9390}, {"maxAge": 1, "name": "Ms. Elizabeth  Donnelly", "title": "Director of Administration", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Maria-Bernadette  Madel Ph.D.", "age": 34, "title": "Director of Corporate Operations & External Communications", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Cheung", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Patricia  Allison", "title": "Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary  Newman Ph.D.", "age": 65, "title": "Head of Regulatory Affairs", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Z. Florkiewicz Sr., Ph.D.", "title": "Senior Director of Molecular Biology & Virology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8598, "open": 0.861, "dayLow": 0.84, "dayHigh": 0.8989, "regularMarketPreviousClose": 0.8598, "regularMarketOpen": 0.861, "regularMarketDayLow": 0.84, "regularMarketDayHigh": 0.8989, "payoutRatio": 0.0, "beta": 1.522, "forwardPE": -0.61424655, "volume": 290931, "regularMarketVolume": 290931, "averageVolume": 2012682, "averageVolume10days": 5170410, "averageDailyVolume10Day": 5170410, "bid": 0.8427, "ask": 0.9177, "bidSize": 4, "askSize": 2, "marketCap": 11603605, "fiftyTwoWeekLow": 0.81, "fiftyTwoWeekHigh": 5.95, "priceToSalesTrailing12Months": 2.153573, "fiftyDayAverage": 1.3558, "twoHundredDayAverage": 1.816, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1141643, "profitMargins": -2.71109, "floatShares": 10386322, "sharesOutstanding": 12938900, "sharesShort": 355844, "sharesShortPriorMonth": 103075, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0275, "heldPercentInsiders": 0.07078, "heldPercentInstitutions": 0.26374, "shortRatio": 0.12, "shortPercentOfFloat": 0.113199994, "impliedSharesOutstanding": 12938900, "bookValue": 0.927, "priceToBook": 0.96742177, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -14607564, "trailingEps": -1.35, "forwardEps": -1.46, "lastSplitFactor": "1:10", "lastSplitDate": 1674777600, "enterpriseToRevenue": 0.212, "52WeekChange": -0.7077922, "SandP52WeekChange": 0.18469036, "quoteType": "EQUITY", "currentPrice": 0.8968, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 10461971, "totalCashPerShare": 0.809, "totalDebt": 0, "quickRatio": 2.837, "currentRatio": 3.452, "totalRevenue": 5388071, "revenuePerShare": 0.499, "returnOnAssets": -0.69385004, "returnOnEquity": -1.44678, "grossProfits": -10481809, "freeCashflow": -6802673, "operatingCashflow": -10883735, "revenueGrowth": -0.263, "grossMargins": -1.9453701, "ebitdaMargins": 0.0, "operatingMargins": -4.94788, "financialCurrency": "USD", "symbol": "MRKR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1757116455, "regularMarketTime": 1757102400, "exchange": "NCM", "messageBoardId": "finmb_1725474", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1026826200000, "shortName": "Marker Therapeutics, Inc.", "regularMarketChangePercent": 4.30333, "regularMarketPrice": 0.8968, "postMarketChangePercent": -3.49019, "postMarketPrice": 0.8655, "postMarketChange": -0.0313, "regularMarketChange": 0.037, "regularMarketDayRange": "0.84 - 0.8989", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2012682, "fiftyTwoWeekLowChange": 0.08679998, "fiftyTwoWeekLowChangePercent": 0.10716047, "fiftyTwoWeekRange": "0.81 - 5.95", "fiftyTwoWeekHighChange": -5.0532, "fiftyTwoWeekHighChangePercent": -0.8492773, "fiftyTwoWeekChangePercent": -70.77922, "dividendDate": 1473984000, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.35, "epsForward": -1.46, "epsCurrentYear": -1.08, "priceEpsCurrentYear": -0.8303703, "fiftyDayAverageChange": -0.45900005, "fiftyDayAverageChangePercent": -0.33854553, "twoHundredDayAverageChange": -0.9192, "twoHundredDayAverageChangePercent": -0.5061674, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "longName": "Marker Therapeutics, Inc.", "displayName": "Marker Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-09-06"}]